ŘÍHA, Pavel, Luboš BRABENEC, Radek MAREČEK, Ivan REKTOR and Irena REKTOROVÁ. The reduction of hippocampal volume in Parkinson's disease. Journal of Neural Transmission. WIEN: SPRINGER WIEN, 2022, vol. 129, 5-6, p. 575-580. ISSN 0300-9564. Available from: https://dx.doi.org/10.1007/s00702-021-02451-8.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The reduction of hippocampal volume in Parkinson's disease
Authors ŘÍHA, Pavel (203 Czech Republic, belonging to the institution), Luboš BRABENEC (203 Czech Republic, belonging to the institution), Radek MAREČEK (203 Czech Republic, belonging to the institution), Ivan REKTOR (203 Czech Republic, belonging to the institution) and Irena REKTOROVÁ (203 Czech Republic, belonging to the institution).
Edition Journal of Neural Transmission, WIEN, SPRINGER WIEN, 2022, 0300-9564.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher Austria
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.300
RIV identification code RIV/00216224:14740/22:00126466
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1007/s00702-021-02451-8
UT WoS 000751224300001
Keywords in English Parkinson's disease; Aging; Hippocampus-to-cortex volume ratio; Processing speed
Tags 14110127, CF MAFIL, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 19/8/2022 12:50.
Abstract
The volume of the hippocampus decreases more slowly than the volume of the cortex during normal aging. We explored changes in the hippocampus-to-cortex volume (HV:CTV) ratio with increasing age in non-demented Parkinson's disease (PD) patients as compared to healthy controls (HC). We also evaluated the association between the HV:CTV ratio and cognitive outcomes. Altogether 130 participants without dementia aged 51-88 years were consecutively enrolled, including 54 PD patients (mean age 67, standard deviation (SD) 8 years) and 76 HC (mean age 69, SD 7 years). All participants underwent structural magnetic resonance examination and psychological evaluation. Hippocampal and cortex volumes were determined from T1 and FLAIR scans using FreeSurfer software, and the HV:CTV ratio was calculated. Regression lines for age-dependence of the HV:CTV ratio for PD and HC groups were calculated. We further assessed the association between the HV:CTV ratio and cognitive tests examining hippocampus-related cognitive functions. PD patients and age-matched HC showed a significant difference in age-dependence of HV:CTV ratio (p value = 0.012), with a decreasing slope in PD and increasing slope in HC. In the PD group, a significant correlation (R = 0.561, p = 0.024) was observed between the HV:CTV ratio and the Digit Symbol-Coding test. The reduction of HV:CTV ratio is accelerated in pathological aging due to PD pathology. The HV:CTV ratio was associated with impaired processing speed, i.e., the cognitive function that is linked to subcortical alterations of both associated basal ganglia circuitry and the hippocampus.
Links
GA21-25953S, research and development projectName: Subkortikální jádra a kortikální funkce z perspektivy hluboké mozkové stimulace (Acronym: DBS3D)
Investor: Czech Science Foundation, Subcortical nuclei and cortical functions – insight from the deep brain stimulation perspective
LM2018129, research and development projectName: Národní infrastruktura pro biologické a medicínské zobrazování Czech-BioImaging
Investor: Ministry of Education, Youth and Sports of the CR
NU20-04-00294, research and development projectName: Diagnostika onemocnění s Lewyho tělísky v prodromálním stadiu založená na analýze multimodálních dat
Investor: Ministry of Health of the CR, Diagnostics of Lewy body diseases in prodromal stage based on multimodal data analysis
734718, interní kód MUName: Novel Network-Based Approaches for Studying Cognitive Dysfunction in Behavioral Neurology (Acronym: CoBeN)
Investor: European Union, MSCA Marie Skłodowska-Curie Actions (Excellent Science)
PrintDisplayed: 13/5/2024 04:08